Maynard Um
-
-
-
-
-
-
-
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at H.C. Wainwright
-
-
-
-
-
-
-
Amylyx launches expanded access program for post-bariatric hypoglycemia drug
-
-
-
-
-
-
-
Amylyx Pharmaceuticals, Inc. (AMLX) Tops Q4 EPS by 4c
-
-
-
-
-
-
-
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $20 at H.C. Wainwright
-
-
-
-
-
-
-
Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (AMLX): Grabar Law Office is Investigating Claims on Your Behalf as Securities Fraud Class Action Survives Motion to Dismiss
-
-
-
-
-
-
-
TD Cowen on Amylyx Pharmaceuticals inc. (AMLX): 'continue to see AMLX as undervalued for the potential of avexitide alone'
-
-
-
-
-
-
-
TD Cowen Starts Amylyx Pharmaceuticals inc. (AMLX) at Buy
-
468,764 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


